Osteoporosis and periodontal disease

Periodontology 2000

Volumn 44, Issue 1, 2007, Pages 29-43

  Geurs, Nico C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT;

AGE; BONE DENSITY; DENTAL CARE; DISEASE PREDISPOSITION; ESTROGEN THERAPY; HEALTH BEHAVIOR; HUMAN; MASS SCREENING; NUTRITIONAL STATUS; OSTEOPOROSIS; PERIODONTAL DISEASE; REVIEW; RISK FACTOR;

AGE FACTORS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DENTAL CARE; DISEASE SUSCEPTIBILITY; ESTROGEN REPLACEMENT THERAPY; HEALTH BEHAVIOR; HUMANS; MASS SCREENING; NUTRITIONAL STATUS; OSTEOPOROSIS; PERIODONTAL DISEASES; RISK FACTORS;

EID: 34247601212     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2006.00194.x     Document Type: Review

References (151)

1. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women's Health Initiative Steering C. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004 : 291 : 1701 1712.
2. Arnaud CD. Osteoporosis: using 'bone markers' for diagnosis and monitoring. Geriatrics 1996 : 51 : 24 30.
3. Arrenbrecht S, Boermans AJ. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial. Osteoporos Int 2002 : 13 : 176 183.
4. Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA III., Berger ML, Santora AC, Sherwood LM. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study. Menopause 2003 : 10 : 412 419.
5. Barzel US. The skeleton as an ion exchange system: implications for the role of acid-base imbalance in the genesis of osteoporosis. J Bone Miner Res 1995 : 10 : 1431 1436.
6. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. J Am Med Assoc 2005 : 293 : 2257 2264.
7. Bjarnason NH, Byrjalsen I, Hassager C, Haarbo J, Christiansen C. Low doses of estradiol in combination with gestodene to prevent early postmenopausal bone loss. Am J Obstet Gynecol 2000 : 183 : 550 560.
8. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996 : 348 : 1535 1541.
9. Brainsky A, Glick H, Lydick E, Epstein R, Fox KM, Hawkes W, Kashner TM, Zimmerman SI, Magaziner J. The economic cost of hip fractures in community-dwelling older adults: a prospective study. J Am Geriatr Soc 1997 : 45 : 281 287.
10. Brown JP, Josse RG, Scientific Advisory Council of the Osteoporosis Society of C. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada [erratum appears in CMAJ 2003: 168: 400]. Can Med Assoc J 2002 : 167 : S1 S34.
11. Cadogan J, Eastell R, Jones N, Barker ME. Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. BMJ 1997 : 315 : 1255 1260.
12. Canalis E. Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996 : 81 : 3441 3447.
13. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997 : 337 : 91 95.
14. Carter ND, Kannus P, Khan KM. Exercise in the prevention of falls in older people: a systematic literature review examining the rationale and the evidence. Sports Med 2001 : 31 : 427 438.
15. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1995 : 122 : 9 16.
16. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB, Women's Health Initiative I. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. J Am Med Assoc 2003 : 290 : 1729 1738.
17. Chesnut CH III., Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 2000 : 109 : 267 276.
18. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund KE, Transbol I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980 : 10 : 273 279.
19. Christiansen C, Christensen MS, Transbol I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981 : 1 : 459 461.
20. Cooper C, Stakkestad JA, Radowicki S, Hardy P, Pilate C, Dain MP, Delmas PD. Matrix delivery transdermal 17beta-estradiol for the prevention of bone loss in postmenopausal women. The International Study Group. Osteoporos Int 1999 : 9 : 358 366.
21. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation [erratum appears in JAMA 1999: 282: 2124]. J Am Med Assoc 1999 : 281 : 2189 2197.
22. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S. Calcium intake and body weight. J Clin Endocrinol Metab 2000 : 85 : 4635 4638.
23. Delmas PD, Pornel B, Felsenberg D, Garnero P, Hardy P, Pilate C, Dain MP. A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group. Bone 1999 : 24 : 517 523.
24. Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R, Mulitple Outcomes of Raloxifene Evaluation I. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 2002 : 87 : 3609 3617.
25. Delmas PD, Rizzoli R, Cooper C, Reginster JY. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int 2005 : 16 : 1 5.
26. Duan Y, Turner CH, Kim BT, Seeman E. Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss. J Bone Miner Res 2001 : 16 : 2267 2275.
27. Egger P, Duggleby S, Hobbs R, Fall C, Cooper C. Cigarette smoking and bone mineral density in the elderly. J Epidemiol Community Health 1996 : 50 : 47 50.
28. Eisman J. Relevance of pregnancy and lactation to osteoporosis Lancet 1998 : 352 : 504 505.
29. Elders PJ, Netelenbos JC, Lips P, van Ginkel FC, Khoe E, Leeuwenkamp OR, Hackeng WH, van der Stelt PF. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 1991 : 73 : 533 540.
30. Elders PJ, Habets LL, Netelenbos JC, van der Linden LW, van der Stelt PF. The relation between periodontitis and systemic bone mass in women between 46 and 55 years of age. J Clin Periodontol 1992 : 19 : 492 496.
31. Ensrud KE, Barrett-Connor EL, Schwartz A, Santora AC, Bauer DC, Suryawanshi S, Feldstein A, Haskell WL, Hochberg MC, Torner JC, Lombardi A, Black DM, Fracture Intervention Trial Long-Term Extension Research G. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension [see comment]. J Bone Miner Res 2004 : 19 : 1259 1269.
32. Ernst E. Exercise for female osteoporosis. A systematic review of randomised clinical trials. Sports Med 1998 : 25 : 359 368.
33. Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003 : 102 : 1225 1232.
34. Eyre DR. Bone biomarkers as tools in osteoporosis management. Spine 1997 : 22 : 17S 24S.
35. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000 : 106 : 1553 1560.
36. Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women [see comment]. J Am Med Assoc 2002 : 288 : 2300 2306.
37. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: are physicians missing an opportunity J Bone Joint Surg Am 2000 : 82-A : 1063 1070.
38. Gallagher JC, Rapuri PB, Haynatzki G, Detter JR. Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers. J Clin Endocrinol Metab 2002 : 87 : 4914 4923.
39. Genant HK. Current state of bone densitometry for osteoporosis. Radiographics 1998 : 18 : 913 918.
40. Geurs NC, Lewis CE, Jeffcoat MK. Osteoporosis and periodontal disease progression. Periodontol 2000 2003 : 32 : 105 110.
41. Grainge MJ, Coupland CA, Cliffe SJ, Chilvers CE, Hosking DJ. Cigarette smoking, alcohol and caffeine consumption, and bone mineral density in postmenopausal women. The Nottingham EPIC Study Group. Osteoporos Int 1998 : 8 : 355 363.
42. Grampp S, Genant HK, Mathur A, Lang P, Jergas M, Takada M, Gluer CC, Lu Y, Chavez M. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification [see comment]. J Bone Min Res 1997 : 12 : 697 711.
43. Greenberg MS. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 : 98 : 259 260.
44. Greenspan SL, Resnick NM, Parker RA. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial. J Am Med Assoc 2003 : 289 : 2525 2533.
45. Gross GJ, Ott CD, Lindsey AM, Twiss JJ, Waltman N. Postmenopausal breast cancer survivors at risk for osteoporosis: physical activity, vigor, and vitality. Oncol Nurs Forum Online 2002 : 29 : 1295 1300.
46. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporosis Int 1997 : 7 : 407 413.
47. Guthrie JR, Ebeling PR, Dennerstein L, Wark JD. Risk factors for osteoporosis: prevalence, change, and association with bone density. Medscape Womens Health 2000 : 5 : E2.
48. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 2000 : 15 : 710 720.
49. Harper KD, Weber TJ. Secondary osteoporosis. Diagnostic considerations. Endocrinol Metab Clin North Am 1998 : 27 : 325 348.
50. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH III., Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. J Am Med Assoc 1999 : 282 : 1344 1352.
51. Heaney RP. The importance of calcium intake for lifelong skeletal health. Calcif Tissue Int 2002 : 70 : 70 73.
52. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V, Weaver C. Peak bone mass. Osteoporos Int 2000 : 11 : 985 1009.
53. Heaney RP, Berner B, Louie-Helm J. Dosing regimen for calcium supplementation [comment]. J Bone Miner Res 2000 : 15 : 2291.
54. Hildebolt CF, Pilgram TK, Yokoyama-Crothers N, Vannier MW, Dotson M, Muckerman J, Armamento-Villareal R, Hauser J, Cohen S, Kardaris EE, Hanes P, Shrout MK, Civitelli R. The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy. J Periodontol 2002 : 73 : 1279 1284.
55. Hotta M, Shibasaki T, Sato K, Demura H. The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual X-ray absorptiometry and bone metabolic markers. Eur J Endocrinol 1998 : 139 : 276 283.
56. International Osteoporosis Foundation. Foundation IO the facts about osteoporosis and its impact. Lyon, France : International Osteoporosis Foundation, 2004. Available at http://www.osteofound.org [accessed August 2006].
57. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D, Women's health initiative I. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006 : 354 : 669 683.
58. Jacobs R, Ghyselen J, Koninckx P, van Steenberghe D. Long-term bone mass evaluation of mandible and lumbar spine in a group of women receiving hormone replacement therapy. Eur J Oral Sci 1996 : 104 : 10 16.
59. Jeffcoat MK. Osteoporosis: a possible modifying factor in oral bone loss. Ann Periodontol 1998 : 3 : 312 321.
60. Jeffcoat MK, Lewis CE, Reddy MS, Wang CY, Redford M. Post-menopausal bone loss and its relationship to oral bone loss. Periodontol 2000 2000 : 23 : 94 102.
61. Jin H, Ralston SH. Genetics of osteoporosis. Curr Rheumatol Rep 2005 : 7 : 66 70.
62. Jonasson G, Bankvall G, Kiliaridis S. Estimation of skeletal bone mineral density by means of the trabecular pattern of the alveolar bone, its interdental thickness, and the bone mass of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 : 92 : 346 352.
63. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994 : 4 : 368 381.
64. Kanis JA, Melton LJ III., Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994 : 9 : 1137 1141.
65. Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B. Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 2000 : 11 : 669 674.
66. Kanis JA, Borgstrom F, Zethraeus N, Johnell O, Oden A, Jonsson B. Intervention thresholds for osteoporosis in the UK. Bone 2005 : 36 : 22 32.
67. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A. Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005 : 16 : 155 162.
68. Kannus P, Haapasalo H, Sankelo M, Sievanen H, Pasanen M, Heinonen A, Oja P, Vuori I. Effect of starting age of physical activity on bone mass in the dominant arm of tennis and squash players. Ann Intern Med 1995 : 123 : 27 31.
69. Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Jarvinen M. Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 1999 : 353 : 802 805.
70. Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999 : 130 : 545 553.
71. Kemmler W, Engelke K, Lauber D, Weineck J, Hensen J, Kalender WA. Exercise effects on fitness and bone mineral density in early postmenopausal women: 1-year EFOPS results. Med Sci Sports Exerc 2002 : 34 : 2115 2123.
72. Khosla S, Melton LJ III., Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001 : 86 : 3555 3561.
73. Kiel DP, Baron JA, Anderson JJ, Hannan MT, Felson DT. Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Intern Med 1992 : 116 : 716 721.
74. Kiel DP, Zhang Y, Hannan MT, Anderson JJ, Baron JA, Felson DT. The effect of smoking at different life stages on bone mineral density in elderly men and women. Osteoporos Int 1996 : 6 : 240 248.
75. Klemetti E, Collin HL, Forss H, Markkanen H, Lassila V. Mineral status of skeleton and advanced periodontal disease. J Clin Periodontol 1994 : 21 : 184 188.
76. Krall EA, Dawson-Hughes B, Papas A, Garcia RI. Tooth loss and skeletal bone density in healthy postmenopausal women. Osteoporos Int 1994 : 4 : 104 109.
77. Kribbs PJ, Smith DE, Chesnut CH Jr. Oral findings in osteoporosis. Part I: measurement of mandibular bone density. J Prosthet Dent 1983 : 50 : 576 579.
78. Kribbs PJ, Smith DE, Chesnut CH Jr. Oral findings in osteoporosis. Part II: relationship between residual ridge and alveolar bone resorption and generalized skeletal osteopenia. J Prosthet Dent 1983 : 50 : 719 724.
79. Kribbs PJ, Chesnut CH III., Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in an osteoporotic population. J Prosthet Dent 1989 : 62 : 703 707.
80. Kribbs PJ, Chesnut CH III., Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in a population of normal women. J Prosthet Dent 1990 : 63 : 86 89.
81. Kroger H, Reeve J. Diagnosis of osteoporosis in clinical practice. Ann Med 1998 : 30 : 278 287.
82. Kroger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S. Bone mineral density and risk factors for osteoporosis - a population-based study of 1600 perimenopausal women. Calcif Tissue Int 1994 : 55 : 1 7.
83. Lees B, Stevenson JC. The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17 beta and dydrogesterone. Osteoporos Int 2001 : 12 : 251 258.
84. Levi G, Geoffroy V, Palmisano G, de Vernejoul MC. Bones, genes and fractures: workshop on the genetics of osteoporosis: from basic to clinical research. EMBO Rep 2002 : 3 : 22 26.
85. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976 : 1 : 1038 1041.
86. Lindsay R, Hart DM, MacLean A, Clark AC, Kraszewski A, Garwood J. Bone response to termination of oestrogen treatment. Lancet 1978 : 1 : 1325 1327.
87. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980 : 2 : 1151 1154.
88. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. J Am Med Assoc 2002 : 287 : 2668 2676.
89. Lindsay R, Burge RT, Strauss DM. One year outcomes and costs following a vertebral fracture. Osteoporos Int 2005 : 16 : 78 85.
90. Lindsay R, Pack S, Li Z. Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis. Osteoporos Int 2005 : 16 : 306 312.
91. Looker AC, Johnston CC Jr., Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Lindsay RL. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res 1995 : 10 : 796 802.
92. Looker AC, Orwoll ES, Johnston CC Jr., Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Prevalence of low femoral bone density in older U.S. adults from NHANES III [see comment]. J Bone Miner Res 1997 : 12 : 1761 1768.
93. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000 : 21 : 115 137.
94. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003 : 61 : 1115 1117.
95. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005 : 63 : 1567 1575.
96. Massey LK. Perspectives. Caffeine and bone: directions for research. J Bone Miner Res 1991 : 6 : 1149 1151.
97. Maxim P, Ettinger B, Spitalny GM. Fracture protection provided by long-term estrogen treatment. Osteoporos Int 1995 : 5 : 23 29.
98. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY, Hip Intervention Program Study G. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 2001 : 344 : 333 340.
99. McKeever C, McIlwain H, Greenwald M, Gupta N, Jayawardene S, Huels G, Roberts M. An estradiol matrix transdermal system for the prevention of postmenopausal bone loss. Clin Ther 2000 : 22 : 845 857.
100. Melton LJ III. Epidemiology worldwide [Review] [68 refs]. Endocrinol Metab Clin North Am 2003 : 32 : 1 13.
101. Melton LJ III., Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective. How many women have osteoporosis? J Bone Miner Res 1992 : 7 : 1005 1010.
102. Melton LJ III., Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL. Bone density and fracture risk in men. J Bone Miner Res 1998 : 13 : 1915 1923.
103. Melton LJ III., Crowson CS, O'Fallon WM. Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 1999 : 9 : 29 37.
104. Melton LJ III., Khosla S, Atkinson EJ, Oconnor MK, Ofallon WM, Riggs BL. Cross-sectional versus longitudinal evaluation of bone loss in men and women. Osteoporos Int 2000 : 11 : 592 599.
105. Migliorati CA. Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol 2003 : 21 : 4253 4254.
106. Mohammad AR, Bauer RL, Yeh CK. Spinal bone density and tooth loss in a cohort of postmenopausal women. Int J Prosthodont 1997 : 10 : 381 385.
107. Mohammad AR, Hooper DA, Vermilyea SG, Mariotti A, Preshaw PM. An investigation of the relationship between systemic bone density and clinical periodontal status in post-menopausal Asian-American women. Int Dent J 2003 : 53 : 121 125.
108. Naessen T, Persson I, Adami HO, Bergstrom R, Bergkvist L. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Ann Intern Med 1990 : 113 : 95 103.
109. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Washington, DC : The Foundation, 1998 : 1 2. Foundation TNO. Retrieved from http://www.nof.org [accessed August 2006].
110. National Osteoporosis Foundation. National Osteoporosis Foundation. Foundation NO America's bone health: the state of osteoporosis and low bone mass in Our Nation. Washington, DC : National Osteoporosis Foundation, 2002.
111. Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 2004 : 180 : S18 S22.
112. North American Menopause S. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. Menopause 2002 : 9 : 84 101.
113. Notelovitz M, John VA, Good WR. Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in healthy, postmenopausal women. Menopause 2002 : 9 : 343 353.
114. Orwoll ES. Osteoporosis in men. Endocrinol Metab Clin North Am 1998 : 27 : 349 367.
115. Ott SM, Oleksik A, Lu Y, Harper K, Lips P. Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women. J Bone Miner Res 2002 : 17 : 341 348.
116. Rae MH, Mole PA, Paterson CR. Endogenous factors affecting bone mineral content in post-menopausal women. Maturitas 1991 : 13 : 319 324.
117. Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med 2005 : 353 : 164 171.
118. Randell A, Sambrook PN, Nguyen TV, Lapsley H, Jones G, Kelly PJ, Eisman JA. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos Int 1995 : 5 : 427 432.
119. Reeve J, Kroger H, Nijs J, Pearson J, Felsenberg D, Reiners C, Schneider P, Mitchell A, Ruegsegger P, Zander C, Fischer M, Bright J, Henley M, Lunt M, Dequeker J. Radial cortical and trabecular bone densities of men and women standardized with the European Forearm Phantom. Calcif Tissue Int 1996 : 58 : 135 143.
120. Reszka AA, Rodan GA. Bisphosphonate mechanism of action. Curr Rheumatol Rep 2003 5 : 65 74.
121. Riggs BL, Hartmann LC. Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice [erratum appears in N Engl J Med 2003: 348: 1192]. N Engl J Med 2003 : 348 : 618 629.
122. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986 : 314 : 1676 1686.
123. Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis [erratum appears in N Engl J Med 1993: 328: 65; author reply 66; PMID: 8416278]. N Engl J Med 1992 : 327 : 620 627.
124. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative I. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002 : 288 : 321 333.
125. Rubinacci A, Peruzzi E, Modena AB, Zanardi E, Andrei B, De Leo V, Pansini FS, Quebe-Fehling E, de Palacios PI. Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women. Menopause 2003 : 10 : 241 249.
126. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004 : 62 : 527 534.
127. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment [see comment]. J Am Med Assoc 2001 : 286 : 2815 2822.
128. Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr. Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 1991 : 6 : 561 567.
129. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Invest 1997 : 100 : 1755 1759.
130. Sloand JA, Schiff MJ. Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia. Am J Kidney Dis 1995 : 26 : 22 26.
131. Southard KA, Southard TE, Schlechte JA, Meis PA. The relationship between the density of the alveolar processes and that of post-cranial bone. J Dent Res 2000 : 79 : 964 969.
132. Specker BL. Evidence for an interaction between calcium intake and physical activity on changes in bone mineral density. J Bone Miner Res 1996 : 11 : 1539 1544.
133. Stone K, Bauer DC, Black DM, Sklarin P, Ensrud KE, Cummings SR. Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1998 : 13 : 1167 1174.
134. Streckfus CF, Johnson RB, Nick T, Tsao A, Tucci M. Comparison of alveolar bone loss, alveolar bone density and second metacarpal bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy. J Gerontol A Biol Sci Med Sci 1997 : 52 : M343 M351.
135. Swezey RL. Exercise for osteoporosis - is walking enough? The case for site specificity and resistive exercise. Spine 1996 : 21 : 2809 2813.
136. Taguchi A, Suei Y, Ohtsuka M, Otani K, Tanimoto K, Hollender LG. Relationship between bone mineral density and tooth loss in elderly Japanese women. Dentomaxillofac Radiol 1999 : 28 : 219 223.
137. Tarassoff P, Csermak K. Avascular necrosis of the jaws: risk factors in metastatic cancer patients [see comment] [comment]. J Oral Maxillofac Surg 2003 : 61 : 1238 1239.
138. Taxel P. Osteoporosis: detection, prevention, and treatment in primary care. Geriatrics 1998 : 53 : 22 28.
139. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 2000 : 71 : 1492 1498.
140. Valimaki MJ, Karkkainen M, Lamberg-Allardt C, Laitinen K, Alhava E, Heikkinen J, Impivaara O, Makela P, Palmgren J, Seppanen R, Vuori I Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. Cardiovascular Risk in Young Finns Study Group. Br Med J 1994 : 309 : 230 235.
141. Von Wactawski-Wende J, Grossi SG, Trevisan M, Genco RJ, Tezal M, Dunford RG, Ho AW, Hausmann E, Hreshchyshyn MM. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol 1996 : 67 : 1076 1084.
142. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy [see comment]. J Oral Maxillofac Surg 2003 : 61 : 1104 1107.
143. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001 : 68 : 259 270.
144. Watts NB. Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA). Osteoporos Int 2004 : 15 : 847 854.
145. Wehren LE. The epidemiology of osteoporosis and fractures in geriatric medicine. Clin Geriatr Med 2003 : 19 : 245 258.
146. Weiss SR, Ellman H, Dolker M. A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group. Obstet Gynecol 1999 : 94 : 330 336.
147. Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry D, O'Connell D, Cranney A, Osteoporosis Methodology Group and The Osteoporosis Research Advisory G. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002 : 23 : 529 539.
148. von Wowern N, Klausen B, Kollerup G. Osteoporosis: a risk factor in periodontal disease. J Periodontol 1994 : 65 : 1134 1138.
149. Wyshak G, Frisch RE. Carbonated beverages, dietary calcium, the dietary calcium/phosphorus ratio, and bone fractures in girls and boys. J Adolesc Health 1994 : 15 : 210 215.
150. Yates J, Barrett-Connor E, Barlas S, Chen YT, Miller PD, Siris ES. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Obstet Gynecol 2004 : 103 : 440 446.
151. Zmuda JM, Cauley JA, Glynn NW, Finkelstein JS. Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men. J Bone Miner Res 2000 : 15 : 1417 1424.